OLUSOLA OLOFINLADE, M.D.
Gastroenterology Physician in LONGVIEW, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
OLUSOLA OLOFINLADE, M.D. filed 1,565 Medicare Part D claims in 2023 as a Gastroenterology Physician in LONGVIEW, Texas, prescribing 88% generic.
- 2K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
OLUSOLA OLOFINLADE, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,565 Top 19% higher than 81% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
OLUSOLA OLOFINLADE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about OLUSOLA OLOFINLADE, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Gastroenterology Physician compares to other specialties among Texas providers
Gastroenterology Physician share within Texas
Gastroenterology Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Gastroenterology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Gastroenterology Physician ABMS/AOA estimate
Est. board-certified rate (Gastroenterology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Gastroenterology Physician US NPIs
Specialty board-certified rate — Gastroenterology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
OLUSOLA OLOFINLADE, M.D. appears in the CMS NPPES registry as a Gastroenterology Physician provider holding M.D. credentials at 701 E MARSHALL AVE, LONGVIEW, TX, 75601, with a listed phone of (903) 236-2222. NPI 1093750531 was issued on 06/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what OLOFINLADE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,565 prescription claims written by this provider, covering 311 Medicare beneficiaries and totaling roughly $253K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Gastroenterology Physician is a mid-sized specialty nationwide, with 16,567 enrolled providers across 54 states and an average of 833 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093750531 |
|---|---|
| Specialty | Gastroenterology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm OLUSOLA OLOFINLADE, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where OLUSOLA OLOFINLADE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for OLUSOLA OLOFINLADE, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$95
Largest payer
Janssen Scientific Affairs, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to OLUSOLA OLOFINLADE, M.D.. To verify OLUSOLA OLOFINLADE, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 1,565 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,191
- Total Day Supply
- 59,163
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $157K
- Generic Drug Cost
- $96K
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 68.0 years
- Avg HCC Risk Score
- 1.76
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 83, 65-74: 144, 75-84: 65, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What OLUSOLA OLOFINLADE, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
411 claims
- Omeprazole 124
Omeprazole
124 claims
- Famotidine 105
Famotidine
105 claims
- Dicyclomine Hcl 98
Dicyclomine Hcl
98 claims
- Sucralfate 87
Sucralfate
87 claims
- Linzess 79
Linzess
79 claims
- Ondansetron Hcl 75
Ondansetron Hcl
75 claims
- Cholestyramine 48
Cholestyramine
48 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 411 |
| Omeprazole | 124 |
| Famotidine | 105 |
| Dicyclomine Hcl | 98 |
| Sucralfate | 87 |
| Linzess Linaclotide | 79 |
| Ondansetron Hcl | 75 |
| Cholestyramine Cholestyramine (With Sugar) | 48 |
| Mesalamine | 38 |
| Metoclopramide Hcl | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gastroenterology Physician Overview
How OLUSOLA OLOFINLADE, M.D. fits within the Gastroenterology Physician landscape nationally.
OLUSOLA OLOFINLADE, M.D.'s 1,565 claims are above the specialty average of 833.
Nearby Gastroenterology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as OLOFINLADE.
Compare Gastroenterology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is OLUSOLA OLOFINLADE, M.D.'s specialty? ▼
How much does OLUSOLA OLOFINLADE, M.D. prescribe under Medicare Part D? ▼
Where is OLUSOLA OLOFINLADE, M.D. located? ▼
What is OLUSOLA OLOFINLADE, M.D.'s NPI number? ▼
Does OLUSOLA OLOFINLADE, M.D. prescribe more brand-name or generic drugs? ▼
How many Gastroenterology Physician providers are there in the US? ▼
What drugs does OLUSOLA OLOFINLADE, M.D. prescribe most often? ▼
Does OLUSOLA OLOFINLADE, M.D. accept Medicare? ▼
How can I verify OLUSOLA OLOFINLADE, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology